ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Fidelity Advisor Growth Strategies Fund Class C

Fidelity Advisor Growth Strategies Fund Class C (FGSHX)

0.00
0.00
(0.00%)
Cerrado 05 Enero 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

FGSHX Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000FU
40000000FU
120000000FU
260000000FU
520000000FU
1560000000FU
2600000000FU

FGSHX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Fidelity Advisor Growth ...?
El precio actual de las acciones de Fidelity Advisor Growth ... es US$ 0.00
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Fidelity Advisor Growth ...?
Fidelity Advisor Growth ... ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
US$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.08M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.62M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
155.16k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
967.95k
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.4M
NITON2OFF Inc
US$ 2.6306
(145.85%)
350.92M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
330.82M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.59M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
259.78M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
222.72M
ElectricMountain53 ElectricMountain53 9 minutos hace
What Lebby said has got no value anymore. He also said deals were around the corner and many other things that haven´t come to fruition. Now he´s fired.
Let´s just wait what Yves has to say next week!!
You posting so much seems like pumping before the 9th!
Are you afraid of wh
LWLG
igotthemojo igotthemojo 31 minutos hace
i am speaking as the foremost authority on kblb that there is...bar none...i am saying that this stock is ready to fly...and will start flying BEFORE Feb...i have spoken...
KBLB
nowwhat2 nowwhat2 34 minutos hace
The Total 3

https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg



Sho nuff.......Whump......Much of this is XRP but I'll betcya Doge, etc. SOL, too

https://investorshub.advfn.com/uimage/uploads/2025/1/
XRPUSD
boi568 boi568 42 minutos hace
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 54 minutos hace
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 56 minutos hace
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 57 minutos hace
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 58 minutos hace
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 59 minutos hace
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 1 hora hace
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 1 hora hace
The Russes hit the jackpot?
BDEZ BDEZ 1 hora hace
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 1 hora hace
Not good, thanks for sharing.
sand sand 1 hora hace
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 1 hora hace
Moving hard soon 
EFSH
mining101 mining101 1 hora hace
Superb
MEGL
benz280c benz280c 1 hora hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 1 hora hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 1 hora hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 1 hora hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 2 horas hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 2 horas hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD

Su Consulta Reciente

Delayed Upgrade Clock